Cal-Maine Vs Vital Farms: Which Egg Stock Should Be in Your Basket?

An analysis comparing Cal-Maine Foods (CALM) and Vital Farms (VITL) highlights CALM as the more compelling investment due to its Strong Buy Zacks Rank, cheaper valuation (16.00x forward earnings vs. VITL's 24.59x), and higher return on equity (48.72% vs. 19.53%). CALM's fiscal 2025 earnings are estimated to surge nearly 300%, driven by higher egg prices and increased sales volumes, while VITL's earnings growth is expected to be more modest, with near-term profitability potentially impacted by investments in its workforce; CALM also offers a dividend yield of 14.7%.

Analysis

The egg industry is navigating price volatility stemming from Highly Pathogenic Avian Influenza (HPAI) outbreaks, which led to the depopulation of 40.2 million birds in 2024 and 33.5 million year-to-date, though the impact intensity has recently lessened. Despite easing prices from record highs, resilient consumer demand, particularly for ethically and sustainably produced eggs, supports an elevated price environment. Cal-Maine Foods (CALM) demonstrated strong performance in its third-quarter fiscal 2025, with earnings per share surging to $10.38 from $3.00 year-over-year and revenues increasing 102% to $1.42 billion, driven by higher net average selling prices and increased total dozens sold, alongside a 5.7% decrease in farm production costs per dozen. CALM is actively expanding its cage-free capacity with $60 million in capital projects and diversifying into value-added egg products via acquisitions like Echo Lake Foods. Its fiscal 2025 earnings per share are forecast by Zacks Consensus Estimate to rise 299.5% to $22.73, although a significant normalization to $5.71 is expected in fiscal 2026. Conversely, Vital Farms (VITL) reported a 9.6% revenue increase to $148 million in its first quarter of fiscal 2025 but experienced a 14% year-over-year decline in earnings per share to 37 cents, attributed to increased investments in crew members. VITL is focused on expanding its premium pasture-raised supply network, targeting $1 billion in net revenues by 2027 with an adjusted EBITDA margin of 12-14%; its fiscal 2025 earnings per share are projected to grow 5.9% to $1.25. Comparatively, CALM trades at a forward 12-month earnings multiple of 16.00x versus VITL's 24.59x, exhibits a superior return on equity (48.72% vs. 19.53%), and provides a 14.7% dividend yield, underpinning its Zacks Rank #1 (Strong Buy) status against VITL's Zacks Rank #3 (Hold).

Key Decisions for Investors

• Investors may consider Cal-Maine Foods for its strong recent financial performance, attractive valuation, robust dividend yield, and strategic capacity expansions, while remaining mindful of the anticipated earnings moderation in fiscal 2026.
• For Vital Farms, investors should assess the company's ability to translate ongoing investments into sustainable earnings growth and achieve its long-term revenue and margin targets, recognizing its premium market positioning but higher current valuation and near-term earnings pressure.
• Market participants should continue to monitor the impact of HPAI on egg supply and pricing dynamics, alongside the sustained consumer preference shift towards cage-free and pasture-raised eggs, which influences the growth trajectory for both companies.